Premium
Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes
Author(s) -
Martin R. J. L.,
Savage D. A.,
Patterson C. C.,
Brady H. R.,
Maxwell A. P.
Publication year - 2007
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2007.02087.x
Subject(s) - haplotype , single nucleotide polymorphism , genetics , diabetic nephropathy , minor allele frequency , genotyping , medicine , genotype , denaturing high performance liquid chromatography , type 2 diabetes , linkage disequilibrium , population , allele frequency , exon , gene , diabetes mellitus , biology , endocrinology , environmental health
Aim Plasminogen activator inhibitor 1 (PAI1) plays a key role in the regulation of extracellular matrix (ECM) degradation. The PAI1 gene is therefore an excellent candidate gene for diabetic nephropathy. The aim of this study was to employ gene resequencing to identify common DNA polymorphisms in the PAI1 gene, and subsequently assess haplotype tagged single nucleotide polymorphisms (htSNPs) using a case control design. Methods All nine exons, exon–intron boundaries, introns 1, 4 and 7 and approximately 3 kb upstream and 5 kb downstream of the PAI1 gene were screened for DNA polymorphisms in 15 case and 15 control subjects using WAVE® denaturing high‐performance liquid chromatography technology and confirmed by DNA sequencing. Polymorphisms were genotyped in 86 healthy individuals using direct sequencing and haplotype tagged single nucleotide polymorphisms (htSNPs) identified. Genotyping of the htSNPs was performed in 583 Type 1 diabetic patients (222 with nephropathy, 361 without nephropathy) using Pyrosequencing. Results Twenty‐one polymorphisms with a minor allele frequency (MAF) > 1% were identified; 14 had a MAF ≥ 10%. Five htSNPs [c.‐1968_69insG, c.43 G→A (Ala15Thr), c.1092‐105 A→G, c.*1737 G→A, c.*3711 C→T] were identified. Haplotype frequencies were similar in case and control groups (likelihood ratio χ 2 test, P = 0.66). Conclusion It is unlikely that common polymorphisms of the PAI1 gene strongly influence susceptibility to diabetic nephropathy in the White Type 1 diabetic population.